Bangalore, 17th March 2025: Peptris Technologies, an AI-powered drug discovery company, announced today that it has entered into a licensing agreement with Revio Therapeutics, a specialty pharma start-up focused on repurposing and optimizing approved medicines. Under the agreement, Peptris is licensing its preclinical-stage asset, PEPR124 (RT001) for an undisclosed amount to Revio Therapeutics for further […]
The post Peptris Technologies Out-Licenses India’s First AI-Discovered Drug to Revio Therapeutics first appeared on Business News Week.